Amgen still needs to show that the reduction in Lp(a) is accompanied by lower rates of cardiovascular outcomes, and will endeavour to show that in its phase 3 programme which will start to enrol a ...

Diamond stock performance hasn't been the greatest over the past few years for investors. However, there’s an expectation that these stocks will experience a rise in the future. Want in the game ...